Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-25-000153 General Corporate
Debt relative to revenue 14th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
77.97% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.84% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
43.67% · OPTIONAL · VALID
Share-count growth 30th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-1.34% · CORE · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
16.89% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
15.03% · OPTIONAL · VALID
Gross margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
61.47% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
26.61% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.03% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.92% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 282.60%
Current 77.97%
Delta -204.64% Capex Intensity Increased
Previous 2.75%
Current 4.84%
Delta 2.09% Cash Generation Increased
Previous 40.45%
Current 43.67%
Delta 3.22% Dilution Decreased
Previous -0.91%
Current -1.34%
Delta -0.42% Growth Decreased
Previous 24.57%
Current 16.89%
Delta -7.68% Inventory Pressure Decreased
Previous 55.44%
Current 15.03%
Delta -40.41% Margin Decreased
Previous 62.14%
Current 61.47%
Delta -0.67% Profitability Decreased
Previous 28.40%
Current 26.61%
Delta -1.79% R And D Intensity Increased
Previous 15.77%
Current 16.03%
Delta 0.26% Sbc Intensity Decreased
Previous 2.94%
Current 2.92%
Delta -0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.